33 related articles for article (PubMed ID: 23216153)
21. Protecting clinical trial participants and protecting data integrity: are we meeting the challenges?
Ellenberg SS
PLoS Med; 2012; 9(6):e1001234. PubMed ID: 22719230
[TBL] [Abstract][Full Text] [Related]
22. Drug-induced cardiac toxicity: emphasizing the role of electrocardiography in clinical research and drug development.
Gussak I; Litwin J; Kleiman R; Grisanti S; Morganroth J
J Electrocardiol; 2004 Jan; 37(1):19-24. PubMed ID: 15132365
[TBL] [Abstract][Full Text] [Related]
23. Assessment of respiratory function in safety pharmacology.
Murphy DJ
Fundam Clin Pharmacol; 2002 Jun; 16(3):183-96. PubMed ID: 12165066
[No Abstract] [Full Text] [Related]
24. Investigational Medical Therapies for Endometriosis: Current Data and Future Trends.
Kavoussi SK; Zhang R; Lebovic DI
Semin Reprod Med; 2017 Jul; 35(4):318-325. PubMed ID: 29036739
[No Abstract] [Full Text] [Related]
25. The problems of the safety evaluation of biotechnology derived drugs.
Caprino L; Togna G
Biomed Environ Sci; 1993 Dec; 6(4):413-8. PubMed ID: 8198758
[No Abstract] [Full Text] [Related]
26. Silence is not the best medicine: requiring disclosure of clinical trial data for abandoned drugs.
Powell B
J Leg Med; 2012 Oct; 33(4):571-92. PubMed ID: 23216153
[No Abstract] [Full Text] [Related]
27. The impact of escalating regulatory requirements on the conduct of clinical research.
Gordon BG; Kessinger A; Mann SL; Prentice ED
Cytotherapy; 2003; 5(4):309-13. PubMed ID: 12944237
[TBL] [Abstract][Full Text] [Related]
28. Clinical trial registries and clinical trial result posting: new paradigm for medical writers.
Foote M
Biotechnol Annu Rev; 2006; 12():379-86. PubMed ID: 17045200
[TBL] [Abstract][Full Text] [Related]
29. Discontinued drugs in 2010: cardiovascular drugs.
Zhao HP; Zhang XS; Xiang BR
Expert Opin Investig Drugs; 2011 Oct; 20(10):1311-25. PubMed ID: 21870899
[TBL] [Abstract][Full Text] [Related]
30. Comparative requirements for exploratory clinical trials -- eIND, eCTA and microdosing.
Muller PY
Adv Drug Deliv Rev; 2011 Jun; 63(7):511-7. PubMed ID: 21034787
[TBL] [Abstract][Full Text] [Related]
31. Task force 1: The ACCF and AHA codes of conduct in human subjects research.
Alpert JS; Shine KI; Adams RJ; Antman EM; Kavey RE; Friedman L; Frye RL; Harrington RA; Korn D; Merz JF; Ofili E
J Am Coll Cardiol; 2004 Oct; 44(8):1724-8. PubMed ID: 15489115
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
